OpenVSafe by OpenVAERS
Search V-safe

8M7-15713-54498

4 vaccinations 12 coded responses 41 check-ins 11 free-text entries 5 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
452 / OH
Registered
2021-02-10
Relationship
Self
Race
N/A
Ethnicity
N/A

Timeline

  1. 2021-02-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-10
    Registered in v-safe
  3. 2021-02-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-03-03
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-03-09
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-03-10
    Dose 2 — Pfizer-BioNTech
  11. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  12. 2021-03-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-03-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-21
    Survey response — day 42, dose 2
    MedDRA: Back pain, Ligament sprain, Muscle strain — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Back muscles went out. Diagnosed with limbo-sacral problem
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-21
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-06-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-09-08
    Survey response — 6 months, dose 2
    MedDRA: Rash, Rash pruritic — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Itchy rash on face
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-09-08
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-09-09
  23. 2021-10-03
    Dose 3 — Pfizer-BioNTech
  24. 2021-10-03
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  26. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Joint pains, Fatigue or tiredness
    Adult check-in
  27. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Joint pains, Muscle or body aches
    Adult check-in
  29. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-10
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-10-17
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-24
    Survey response — day 21, dose 3
    MedDRA: Dizziness, Rash — Feeling: Good
    Free text: Rash on arm. Dizziness
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-11-01
    Survey response — day 28, dose 3
    MedDRA: Rash — Feeling: Good
    Free text: Rash
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-11-07
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-16
    Survey response — day 42, dose 3
    MedDRA: Arthralgia, Rash — Feeling: Good
    Free text: Rash and joint pain
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-01-04
    Survey response — 3 months, dose 3
    MedDRA: Arthralgia, Dizziness, Dyspnoea, Memory impairment, Migraine, Visual impairment — Feeling: Good · Be unable to do your normal daily activities
    Free text: Occasional dizziness and migraine headaches, greater degree if forgetfulness, joint aches, shortness of breath, deteriorating eyesight
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-04-03
    Survey response — 6 months, dose 3
    MedDRA: Drooling, Dyspnoea, Stomatitis — Feeling: Good
    Free text: Sores on inside of mouth. Some uncontrolled drooling from right side of mouth. Some shortness of breath.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-05-03
    Dose 4 — Pfizer-BioNTech
  39. 2022-05-04
    Survey response — days 1–6 daily, dose 4
    MedDRA: Gait disturbance — Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Difficulty walking long distances
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-05-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  41. 2022-05-06
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  42. 2022-05-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  43. 2022-05-09
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  44. 2022-05-11
    Health check-in — day 7, dose 4
    Feeling: Good · Joint pains, Fatigue or tiredness
    Adult check-in
  45. 2022-05-17
    Survey response — day 14, dose 4
    MedDRA: Myalgia — Feeling: Good
    Free text: More severe hip muscle pain.
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-05-26
    Survey response — day 21, dose 4
    MedDRA: Bursitis, Musculoskeletal stiffness, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Bursitis in hip and lower back. Morning stiffness · Healthcare visit (other): Medical specialist visit
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-05-26
    Report sent to call center — day 21, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  48. 2022-05-27
    Call successful
    Participant prefers to complete VAERS report online
  49. 2022-05-27
    Call successful
    Participant prefers to complete VAERS report online
  50. 2022-05-27
    Call successful
    Participant prefers to complete VAERS report online
  51. 2022-06-02
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-08-04
    Survey response — 3 months, dose 4
    MedDRA: Dizziness, Meningioma, Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Meningiomas discovered in brain. Constant dizziness. Occasional rashes
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-08-04
    Report sent to call center — 3 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  54. 2022-08-05
    Call successful
    Participant prefers to complete VAERS report online
  55. 2023-05-03
    Survey response — 12 months, dose 4
    MedDRA: Balance disorder, Goitre, Headache, Ligament sprain, Olfactory groove meningioma, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  56. 2023-05-03
    Report sent to call center — 12 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  57. 2023-05-04

Vaccinations

DoseDateManufacturerCo-administered
12021-02-09Pfizer-BioNTech
22021-03-10Pfizer-BioNTech
32021-10-03Pfizer-BioNTech No
42022-05-03Pfizer-BioNTech No

Call center

5 call center cases

4 successful · 1 unsuccessful

See the call center timeline

Free text

Release 7 — day 42, dose 2

2021-04-21

Symptoms: Back muscles went out. Diagnosed with limbo-sacral problem

Release 9 — 6 months, dose 2

2021-09-08

Symptoms: Itchy rash on face

Release 10 — day 21, dose 3

2021-10-24

Symptoms: Rash on arm. Dizziness

Release 10 — day 28, dose 3

2021-11-01

Symptoms: Rash

Release 10 — day 42, dose 3

2021-11-16

Symptoms: Rash and joint pain

Release 10 — 3 months, dose 3

2022-01-04

Symptoms: Occasional dizziness and migraine headaches, greater degree if forgetfulness, joint aches, shortness of breath, deteriorating eyesight

Release 11 — 6 months, dose 3

2022-04-03

Symptoms: Sores on inside of mouth. Some uncontrolled drooling from right side of mouth. Some shortness of breath.

Release 11 — days 1–6 daily, dose 4

2022-05-04

Systemic reaction (other): Difficulty walking long distances

Release 11 — day 14, dose 4

2022-05-17

Symptoms: More severe hip muscle pain.

Release 11 — day 21, dose 4

2022-05-26

Symptoms: Bursitis in hip and lower back. Morning stiffness
Healthcare visit (other): Medical specialist visit

Release 12 — 3 months, dose 4

2022-08-04

Symptoms: Meningiomas discovered in brain. Constant dizziness. Occasional rashes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDArthralgia · · ✓
SDBack pain ○ ✓ ○
SDBalance disorder · · ✓
SDBursitis · · ✓
SDDizziness · · ✓
SDDrooling · · ✓
SDDyspnoea · · ✓
SDGoitre · · ✓
SDHeadache · · ✓
SDLigament sprain ○ ✓ ✓
SDMemory impairment · · ✓
SDMeningioma · · ✓
SDMigraine · · ✓
SDMuscle strain ✓ · ✓
SDMusculoskeletal stiffness · · ✓
SDMyalgia · · ✓
SDOlfactory groove meningioma · · ✓
SDRash · · ✓
SDRash pruritic · · ✓
SDStomatitis · · ✓
SDUnevaluable event · · ✓
SDVisual impairment · · ✓
SROGait disturbance · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release